Amryt Pharma

Irish pharma company Amryt almost doubles CEO pay to $1.6m

Chief executive Joe Wiley also received more than 6m share options in company

Amryt Pharma files registration statement for impending Nasdaq listing

Company recently signed distribution agreement with Swixx BioPharma

Biopharma group Amryt reports 30% jump in revenue

Rare disease specialist says integration with newly acquired Aegerion completed ahead of time

Amryt Pharma recorded 13.1% rise in revenue last year

Company said the impact of Covid-19 on its business has been minimised so far

Amryt says integration of acquired company Aegerion ‘progressing well’

Dublin-based biopharma company has cash position of $60.9m

‘Serious gender imbalance’ remains at top of Irish business, report finds

New targets set for inclusion of women on leadership teams and in private companies

Dublin pharma company Amryt grows sales almost 20%

Firm acquired US-based Aegerion Pharmaceuticals earlier this year

Venn signs deal with Open Orphan to focus on rare diseases

Company has issued €1.1m in loan notes to fund specialisation in orphan diseases

Iseq slumps to lowest since Brexit referendum as key vote delayed

Markets also rattled by growing unrest in France and fresh China-US trade concerns

Government provides €75m in funding for ‘disruptive’ projects

Company that received the most funding was biopharmaceutical group Amryt Pharma

Carrick Therapeutics head Sullivan named best emerging entrepreneur

Elaine Sullivan leads cancer research firm to an EY Entrepreneur of the Year Award

Irish shares advance for first time in five sessions

European markets buoyed by speculation that US could resume trade talks with China

Sales of Amryt Pharma cholesterol drug up 14.6%

Amyrt’s EB development asset progressing through phase three clinical trial

Amryt skin therapy trial gets green light in US

Approval for treatment for rare genetic condition paves way for clinical trials in US

Amryt Pharma wins key US drug designation

FDA move means Irish company could receive voucher ultimately worth up to €300m

Amryt Pharma heart drug wins approval from NHS England

Drug treats rare condition which can lead to early blocking of arteries and heart attacks

Dublin entrepreneur targeting treatments for rare diseases

EY Entrepreneur of the Year finalist Dr Joe Wiley of Amryt Pharma

Amryt signs new deal to expand Lojuxta licence

Firms estimates new deal will increase number of patients for treatment by 25%

EY Entrepreneur of the Year: 24 companies shortlisted for award

Finalists employ more than 2,700 people and generate annual revenues of €150m

Amryt Pharma signs distribution agreement in middle east

Company has further expanded its market coverage for Lojuxta

Amryt Pharma appoints new head of regulatory affairs

Derval O’Carroll has more than 25 years experience in pharmaceutical industry

Amryt Pharma signs deal for drug distribution in Switzerland

Lojuxta deal is ‘key step’ in growing company’s business for drug in EMEA region

Amryt Pharma to raise €15m to treat rare skin disorder

Placing is conditional on shareholder approval at a general meeting on October 9th

Sales jump at rare disease drug group Amryt Pharma

Company starts phase III trial for ‘butterfly skin’ disease

Here's what’s happening in the business week ahead

For Your Diary: Exchequer returns; Dalata results; Dell results; ECB rate decision

AIB tops €5 as banks globally surge ahead

Applegreen and Providence also enjoy gains

Amryt Pharma enrols first patient on EB drug trial

Irish company says therapy for skin blistering condition is its prime pipeline candidate

All the major business events happening this week

For Your Diary: Dell, Ladbrokes Coral and Datalex report;Theresa May triggers Brext

Declines in miners, energy producers drag equities lower

Investors worry central banks less willing to use monetary policy to stimulate growth

Fastnet shareholders back Amryt Pharma reverse takeover

All-cash deal for Fastnet also involved raising £10m (€12.5m) for future acquisitions

Cantillon: Fastnet chief explains switch to pharma

Fastnet Oil & Gas shareholders to be asked to approve reverse takeover by Amryt Pharma

YOU MAY ALSO LIKE...

The Irish Times ePaper